The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company ... in the US and EU as a subcutaneous injection lasting a few minutes, instead ...

Xolair (omalizumab) is a brand-name subcutaneous injection that’s prescribed for hives, asthma, and other conditions. This article covers topics such as side effects, dosage, and how Xolair works.

Roche has reported findings from Stage I of the Phase III OUtMATCH study of the immunoglobulin E (IgE)-targeting antibody Xolair (omalizumab) in people with multiple food allergies. Sponsored by ...